Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Neurology International|July 27, 2013
Relation of helicobacter pylori infection and multiple sclerosis in Iranian patientsNafiseh Mohebi, Mansoureh Mamarabadi, Mehdi Moghaddasi
Neurology International|October 22, 2015
Relapsing Remitting Multiple Sclerosis in an Iranian Patient with Neurofibromatosis Type INafiseh Mohebi, Mehdi Moghaddasi, Zaribafian Maryam
Acta Medica Iranica|December 17, 2013
Amyotrophic lateral sclerosis as a paraneoplastic manifestation in the neuroendocrine tumor of stomach: a case reportMasoud Mehrpour, Nafiseh Mohebi, Mohammad Reza Motamed, et al.
Clinical Neurology and Neurosurgery|June 13, 2013
Homocysteine, vitamin B12 and folate levels in Iranian patients with Multiple Sclerosis: a case control studyMehdi Moghaddasi, Mansoureh Mamarabadi, Nafiseh Mohebi, et al.
IBRO Neuroscience Reports|September 17, 2025
The miR-133b and miR-206 serum levels as a candidate biomarker in Alzheimer's patients with dyslipidemiaShahram Darabi, Enam Alhagh Gorgich, Auob Rustamzadeh, et al.
Acta Psychologica|February 8, 2024
Effectiveness of intensive short-term dynamic psychotherapy for Tension-Type Headache (TTH): A randomized controlled trial of effects on emotion regulation, anger, anxiety, and TTH symptom severityZahra Ahmadvand Shahverdi, Mahmood Dehghani, Ahmad Ashouri, et al.
Journal of Neurology|August 10, 2019
Stroke in supplementary motor area mimicking functional disorder: a case reportNafiseh Mohebi, Mahsa Arab, Mehdi Moghaddasi, et al.
Obesity Surgery|February 14, 2025
The Influence of Metabolic and Bariatric Surgery on Cardiovascular Health in Women: A Comprehensive StudyShokoufeh Hajsadeghi, Rahmatullah Athar, Aida Iranpour, et al.
IBRO Neuroscience Reports|August 14, 2024
Effects silymarin and rosuvastatin on amyloid-carriers level in dyslipidemic Alzheimer's patients: A double-blind placebo-controlled randomized clinical trialAuob Rustamzadeh, Nader Sadigh, Zahra Vahabi, et al.
Metabolic Brain Disease|June 19, 2024
Rosuvastatin attenuates total-tau serum levels and increases expression of miR-124-3p in dyslipidemic Alzheimer's patients: a historic cohort studyFarnoosh Usefi, Auob Rustamzadeh, Zahra Ghobadi, et al.
Pageof 2